metaLead Therapeutics secured CHF 1 million in funding from the UZH Life Sciences Fund (LSF)
01 May 2025
01 May 2025
Total investments received (USD): 1.07m
Round value (USD): 1.07m
Round investors:
UZH Life Sciences Fund
Company: metaLead Therapeutics
Industry:
Health services
Pharma
Related deals
Stalicla in a CHF2M with Addex Therapeutics
Investments
05 June 2025
CGC Genomics raised €1.7m in pre-seed funding with Heal Capital, Becker Ventures, Springboard Health Angels, Superangels and Better Ventures
Investments
04 April 2025
InVirtuoLab in a funding round of €2.85 million
Investments
04 February 2025
Belgium
Netherlands
Austria
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain
United Kingdom